+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amobarbital"

Sleep Disorder Treatment Drugs Markets in China - Product Thumbnail Image

Sleep Disorder Treatment Drugs Markets in China

  • Report
  • February 2024
  • 227 Pages
  • China
From
Sleep Disorder Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Sleep Disorder Treatment Drugs Industry Forecasts - China Focus

  • Report
  • February 2024
  • 114 Pages
  • China
From
Amobarbital (CAS 57-43-2) Global Market Research Report 2024 - Product Thumbnail Image

Amobarbital (CAS 57-43-2) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Amobarbital is a barbiturate drug used to treat anxiety, insomnia, and seizures. It is classified as a central nervous system (CNS) depressant, and is used to reduce the activity of the brain and nervous system. It is also used as a sedative and anesthetic. Amobarbital is typically administered orally, intravenously, or intramuscularly. It is available in both generic and brand-name formulations. Amobarbital is used to treat a variety of conditions, including anxiety, insomnia, and seizures. It is also used as a pre-operative sedative and anesthetic. It is sometimes used to treat alcohol withdrawal symptoms, and is sometimes used in combination with other drugs to treat certain types of pain. The amobarbital market is highly competitive, with a number of companies offering generic and brand-name formulations. Some of the major players in the market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more